Global Microbiome Sequencing Services Market 2018-2022
About Microbiome Sequencing Services
Microbiome sequencing helps in analyzing microbial communities found in the human body and finding their impact on disease diagnosis.
Technavio’s analysts forecast the global microbiome sequencing services market to grow at a CAGR of 22.10% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global microbiome sequencing services market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Microbiome Sequencing Services Market 2018-2022
Technavio recognizes the following companies as the key players in the global microbiome sequencing services market: BGI, Clinical-Microbiomics, Diversigen, GATC Biotech, and Second Genome.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is growing awareness of microbiome in cancer development and therapy. The knowledge regarding interactions between host and microbiome can help understanding the impact which microbes have on human health. Microbes can have both positive and negative impact on health and hence, this knowledge can help researchers understand the contribution of microbiome community in both cancer development as well as its therapy.”
According to the report, one driver in the market is rise in chronic and infectious diseases. Over the years, the prevalence of chronic and infectious diseases such as malaria, tuberculosis, HIV AIDS, and hepatitis has increased rapidly. For instance, according to the CDC, 3.2 billion people around the world are at risk of malaria.
Further, the report states that one challenge in the market is high cost of sequencing systems. Although NGS has significantly reduced the cost of microbiome, the products and services used in NGS are expensive, therefore, small-scale laboratories cannot buy them. Since, microbiome sequencing involves handling high throughput data, maintaining precision and accuracy, it requires highly professional personnel and cutting-edge technology and machinery.
BGI, Clinical-Microbiomics, Diversigen, GATC Biotech, and Second Genome.